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Abstract: Although once considered a disease of adults, the prevalence of type 2 diabetes 
in youth is increasing at a significant rate. Similar to adults, youth with type 2 diabetes are 
at increased risk for developing hypertension, lipid abnormalities, renal disease, and other 
diabetes-related complications. However, children and adolescents with type 2 diabetes also 
face many unique management challenges that are different from adults with type 2 diabetes 
or children with type 1 diabetes. To deliver safe, effective, high-quality, cost-effective health   
care to adolescents with type 2 diabetes, reorganization and redesign of health care systems are 
needed. Multidisciplinary health care teams, which allow individuals with specialized training 
to maximally utilize their skills within an organized diabetes treatment team, may increase 
efficiency and effectiveness and may improve outcomes in children with type 2 diabetes. This 
review article provides a brief review of type 2 diabetes in children and adolescents, provides 
an overview of multidisciplinary health care teams, and discusses the role of multidisciplinary 
health care management in youth with type 2 diabetes.
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Introduction
The prevalence of type 2 diabetes in children and adolescents is increasing worldwide.1–3 
The potential cumulative morbidity and mortality resulting from early-onset type 
2 diabetes is staggering. However, to date, little evidence on the pathophysiology, 
management, complications, and long-term outcomes of type 2 diabetes in youth is 
available. As a result, experience from adults with type 2 diabetes or children with 
type 1 diabetes has been extrapolated to adolescents, but emerging evidence suggests 
that there are important differences in the disease between these populations.4 In order 
to curb the rising epidemic, novel disease management strategies are needed with a 
focus on care organization, delivery, and patient and family behavioral modification. 
These challenges are best approached by an organized, multidisciplinary health care 
team focused on delivering high-quality patient care. This review seeks to provide an 
overview of type 2 diabetes in youth, describe important components of multidisci-
plinary health care teams, and provide recommendations for future research.
Classification of diabetes in youth
Diabetes is classically conceptualized into 2 distinct entities: type 1 diabetes and type 2 
diabetes. Type 1 diabetes results from an absolute deficiency in insulin secretion due 
to cell-mediated autoimmune destruction of pancreatic β-cells. Type 2 diabetes results 
from a combination of insulin resistance and inadequate insulin secretion.5 Classically, Journal of Multidisciplinary Healthcare 2010:3 submit your manuscript | www.dovepress.com
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patients with type 1 diabetes present with thin body habitus, 
lack of insulin production, presence of   autoantibodies to 
  insulin or pancreatic islet cells, and ketoacidosis, whereas 
patients with type 2 diabetes present with overweight, 
evidence of increased insulin or insulin resistance, lack of 
autoantibodies, and no ketoacidosis. However, differentiation 
between type 1 and type 2 diabetes can be more challenging 
in pediatric patients.4,6–8 Among pediatric patients clinically 
diagnosed with type 2 diabetes, up to 33% have ketoaci-
dosis at the time of presentation.6 Although autoantibodies 
are   classically present in type 1 diabetes, up to 4%–7% of 
  children with newly diagnosed type 1 diabetes are autoan-
tibody negative,9 and 10%–75% of children with clinically 
diagnosed type 2 diabetes have detectable autoantibodies.6,10,11 
Additionally, up to one-fourth of patients with type 1 diabetes 
present overweight.1
Epidemiology of type 2 diabetes  
in children and adolescents
Epidemiologic studies in type 2 diabetes are limited by 
the challenges of correct clinical classification of diabetes. 
Numerous reports have demonstrated global, dramatic 
increases in pediatric patients with type 2 diabetes, although 
the rate of increase varies widely between countries and 
ethnic groups. Most studies are based on case series, clinic 
cohorts, or registry data. Thus, the incidence and prevalence 
estimates may be subject to bias. The Pima Indians in North 
America have the world’s highest reported incidence of 
diabetes12 with an estimated prevalence of type 2 diabetes of 
5,100 per 100,000 adolescents in the 1990s.8,13   Subsequently, 
North American case series have found that type 2   diabetes 
accounts for 8%–46% of diabetes in newly diagnosed 
patients aged 0–19 years.7,8 Population-based studies have 
found more modest prevalence estimates. The National 
Health and   Nutrition Examination Survey III (NHANES III) 
  estimated a diabetes prevalence (unknown type of diabetes) of 
4,100 per 100,000 adolescents aged 12–19 years in the United 
States.7 The SEARCH for Diabetes in Youth Study   conducted 
  population-based ascertainment of diabetes in youth younger 
than 20 years in six geographically diverse regions of the 
United States. In this study, the overall prevalence of type 2 
diabetes was 22 per 100,000 youth, whereas overall   incidence 
was 24.3 per 100,000 person-years. Incidence and   prevalence 
of type 2 diabetes in youth were highest among ethnic 
  minorities and observed to increase with age.14,15
International studies have also demonstrated an increasing 
incidence and prevalence of type 2 diabetes in youth, although 
the rate of increase appears to be less than that observed in North 
American studies.12 In Japan, the incidence of type 2 diabetes 
observed in a school-based urine glucose screening program 
was 3 per 100,000 youth, with more than 80% of   children with 
type 2 diabetes being obese.16 A nationwide diabetes screening 
program among school children in   Taiwan found that 54% of 
newly diagnosed diabetics were type 2, with an incidence rate 
of 6.5 per 100,000.17 Between 2001 and 2006, the incidence 
rate of type 2 diabetes in the   Australasian   Paediatric Endocrine 
Group New South Wales (NSW)   Diabetes Register was 2.5 per 
100,000 person-years, with type 2 diabetes accounting for 11% 
of incident diabetes diagnoses in youth aged 10–18 years.18 
European incidence estimates of type 2 diabetes range from 
0.25–1.52 per 100,000 youth.12,19
Although the incidence and prevalence of type 2 diabetes 
in youth are increasing, the rates of increase do not currently 
appear to be of “epidemic” proportions.20 The appearance of 
type 2 diabetes in adolescents seems to mirror the increase 
in type 2 diabetes in adult populations throughout the world, 
although the appearance and rate of increase in children lag 
behind what has been observed in adults. Attention to the 
epidemiology of type 2 diabetes in adults may predict the 
patterns of emergence of type 2 diabetes in adolescents.12
Risk factors
Risk factors for type 2 diabetes in children have been   identified 
largely from case series, patient or disease   registries, and 
  clinic-based cohorts. The well-characterized risk factors 
include race or ethnicity, family history, obesity, physical 
inactivity, low birth weight, intrauterine exposure to maternal 
  diabetes, puberty, gender, and conditions predisposing to   insulin 
  resistance such as polycystic ovarian syndrome.2,8,21–25
Irrespective of country of residence, children of American 
Indian, Alaskan Native, Asian American, Pacific Islander, 
Hispanic, and African American ethnic groups have the 
highest rates of type 2 diabetes, with American Indian and 
Canadian First Nation youth having the highest prevalence 
overall.7,26 Globally, Indo-Asians appear to be the most at risk 
group, and this may be related to a tendency toward central 
adiposity.21 African American children have higher insulin 
levels in response to an oral glucose tolerance test (OGTT) 
when compared with white children, even after adjustment 
for weight, age, and pubertal stage.8,27 Data suggest that 
minority children may have a genetic predisposition to insulin 
resistance that interacts with environmental modulators and 
predisposes to the development of type 2 diabetes.8
Between 45% and 80% of pediatric patients with type 
2 diabetes have at least one parent with diabetes, and 
74%–100% of children have a first- or second-degree Journal of Multidisciplinary Healthcare 2010:3 submit your manuscript | www.dovepress.com
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  relative with type 2 diabetes.2,25 Japanese children with type 
2 diabetes demonstrate familial clustering, with 48%–60% 
of parents having diabetes and siblings having a 175- to 
250-fold increase in diabetes when compared with the 
  general population.2 Physical, behavioral, and environmental 
risk factors appear to be pervasive throughout the family. 
  Adolescents with type 2 diabetes often belong to high-risk 
family units, having parents and siblings with increased 
central obesity, increased rates of type 2 diabetes and insulin 
resistance, and diets high in fat and low in fiber.28
Obesity may be the most important determinant of insulin 
resistance and type 2 diabetes.25 Globally, the risk in type 2 
diabetes mirrors urbanization and economic development, and 
obesity appears to be the key link.2 The incidence of type 2 dia-
betes in Japan paralleled the increasing prevalence of obesity 
in school children from 1974 to 1995.2,29 This has also been 
observed in China, Hong Kong, England,   Australia, and the 
United States.2 Up to 85% of children presenting with type 2 
diabetes are obese or overweight,21 and adiposity accounts for 
approximately 50% of the variance seen in insulin sensitivity.25 
The impact of overweight and obesity is further compounded 
by decreased physical activity, decreased participation in 
physical education, and increased television viewing com-
monly observed in this population.2 Dietary behaviors can 
contribute to excessive weight gain and may also contribute to 
the development of type 2 diabetes in children.2 In adults, con-
sumption of sugar-sweetened beverages has been   associated 
with weight gain, obesity, and risk for diabetes.30,31
Other potential risk factors for the development of type 2 
diabetes include low or high birth weight, rapid weight gain, 
puberty, and gender. Low birth weight, high birth weight, and 
maternal diabetes are associated with increased risk of type 2 
diabetes in Pima Indian youth.7,32 Low birth weight has been 
associated with increased risk for glucose intolerance, type 2 
diabetes, and metabolic syndrome in adult life, although the 
mechanisms remain largely unknown.33   Additionally, rapid 
weight gain in early childhood is a risk factor for   subsequent 
obesity and type 2 diabetes in   adulthood.25 Puberty confers 
a state of relative insulin resistance and also increases 
basal and stimulated insulin responses.25 Although little 
gender   variation is observed in adults with type 2 diabetes, 
  adolescent girls are nearly twice as likely to develop type 2 
diabetes compared with boys.2,3
Diagnosis
Diabetes diagnostic criteria are identical in children and 
adults (Table 1). The presence of a random plasma   glucose 
level $200 mg/dL ($11.1 mmol/L) associated with   classic 
symptoms of hyperglycemia (polyuria,   polydipsia, and 
  unexplained weight loss), plasma glucose level $200 mg/dL 
($11.1 mmol/L) 2 hours after a 75-g OGTT, or fasting plasma 
glucose level $126 mg/dL ($7.0 mmol/L) on two   separate 
days confirms a diagnosis of diabetes.5,34   Additionally, in 
2009, hemoglobin A1c (HbA1c) was added as a diagnostic 
tool.34 Individuals with HbA1c between 6.0% and 6.5% can 
be considered “at risk,” while $6.5% can be considered a 
new diagnosis of diabetes.34
Although widely accepted, these diagnostic criteria are 
based on data from adult populations and extrapolated to 
children and adolescents. Mounting evidence suggests that 
pathology and physiology of disease differ between children 
and adults.2 Fasting plasma glucose level and OGTT have 
not been evaluated in rigorous, large studies in children. The 
correct “dose” of glucose for the OGTT and the expected 
response in children are unknown. Additionally, the impact 
of variation in glucose metabolism throughout childhood, 
including increased insulin resistance during the pubertal 
period, is unknown and unaccounted by current diagnos-
tic methods.21 Further research is needed to determine the 
performance of current diagnostic criteria for diabetes in 
children and adolescents.
Screening
Screening programs for type 2 diabetes seek to identify 
asymptomatic individuals who are likely to have disease. 
Onset of type 2 diabetes in childhood results in longer dura-
tion of disease, increased medical costs, higher lifetime rates, 
and earlier development of microvascular and macrovascular 
complications.2 Although routine screening for type 2 dia-
betes in children seems intuitive, the overall prevalence of 
type 2 diabetes and the prevalence of undiagnosed disease 
are low.4 General screening programs of school-age children 
Table 1 Diagnostic tests for impaired glucose regulation and 
diagnosis of diabetes5,32
Test
Fasting blood 
glucose,a mg/dL 
(mmol/L)
2-h plasma  
glucose,b mg/dL 
(mmol/L)
Hemoglobin 
A1c
Normal ,100 (,5.6) ,140 (,7.8) –
impaired 
fasting 
glucose
100–125 (5.6–6.9) – –
impaired 
glucose 
tolerance
– 140–199 (7.8–11.0) –
Diabetes $126 ($7.0) $200 ($11.1) $6.5
Notes: aMinimum 8-h fast; bFollowing a 75-g oral glucose tolerance test (OGTT).Journal of Multidisciplinary Healthcare 2010:3 submit your manuscript | www.dovepress.com
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in Japan and Taiwan cost nearly US $10,000 per case of type 
2 diabetes identified.2 Relatively low disease prevalence and 
the high costs of universal screening have led to targeted 
screening in high-risk groups.
Current recommendations supported by the American 
Diabetes Association (ADA) and the International Diabetes 
Federation support the targeted screening of high-risk chil-
dren and adolescents, beginning at 10 years of age or the onset 
of puberty, who meet the criteria outlined in Table 2.1,2,35 
Based on convenience, cost, and ease of performance, fasting 
plasma glucose test, rather than the OGTT, is the preferred 
screening test.2,35
Strict utilization of these screening recommendations 
would lead to screening of approximately 10% of youth 
or approximately 2.5 million adolescents between the ages 
of 12 and 19 years in the United States. An estimated 5% 
of screened youth may have impaired fasting glucose or 
undiagnosed diabetes.2 Given the low prevalence of type 
2 diabetes in children and adolescents, screening tests are 
more likely to identify children with prediabetes rather than 
those with diabetes. This is suggested by NHANES data from 
the United States where between 1999 and 2000, no cases 
of type 2 diabetes were identified among adolescents aged 
12–19 years, but nearly 18% of adolescents with obesity had 
impaired fasting glucose.36 Currently, effective management 
and treatment strategies of prediabetic states in children are 
unknown,4 and there is a lack of evidence that screening 
for type 2 diabetes in childhood decreases disease-related 
morbidity and mortality or demonstrates cost-effectiveness.35 
Currently, adherence to screening guidelines is sporadic, 
with ,50% of children meeting screening criteria receiving 
screening and utilization of a random plasma glucose rather 
than fasting plasma glucose or OGTT.37
Complications
Onset of type 2 diabetes in adolescence may place the 
  individuals at risk for increased morbidity and mortality 
  during their most productive life-years; however, limited long-
term follow-up studies describing secondary complications of 
type 2 diabetes in children and adolescents are available.
Young adults aged 18–44 years with type 2 diabetes 
develop microalbuminuria and cardiovascular disease more 
rapidly than individuals diagnosed after age 45 and have 
a 14-fold relative increase in myocardial infarction risk 
compared with age-matched and gender-matched controls 
without diabetes.38 In spite of shorter disease duration, 
many studies have demonstrated the greater prevalence 
of   microalbuminuria in adolescents with type 2 diabetes 
  compared with individuals with type 1 diabetes.39 Among 
Pima Indians with incident type 2 diabetes, microalbuminuria 
was present in 22% of adolescents at diagnosis and 58% after 
10 years of follow-up.40
Although retinopathy remains more frequent in patients 
with type 1 diabetes, it may be present in adolescents with 
type 2 diabetes at the time of diagnosis, and patients with 
type 2 diabetes have a notably shorter duration of disease 
prior to its appearance.41 Up to 9% of patients diagnosed with 
type 2 diabetes before age 30 have evidence of retinopathy at 
diagnosis, and nearly 13% develop proliferative retinopathy 
before age 35.42 Limited data suggest that rates of peripheral 
and autonomic neuropathy do not differ among adolescents 
with type 1 and type 2 diabetes; however, adolescents with 
type 2 diabetes appear to develop neuropathy at a more 
rapid rate.41,43
The presence of comorbid conditions, such as   hypertension, 
dyslipidemia, and nonalcoholic fatty liver disease (NAFLD) 
is well documented in adolescents with type 2 diabetes. 
These illnesses are intimately associated with obesity and 
exist concurrently with diabetes in many patients. Hyperten-
sion is eight times more prevalent at the time of diagnosis in 
adolescents with type 2 diabetes compared with those with 
type 1 diabetes, with prevalence estimates ranging from 
10%–32%.39 Dyslipidemia is also common with 18%–46% 
of adolescents with type 2 diabetes having elevated low-
density lipoproteins and 29%–61% of individuals having 
elevated triglycerides.39 Elevated liver enzymes have been 
noted in up to 48% of adolescents with type 2 diabetes. In the 
  setting of obesity, insulin resistance, dyslipidemia, and type 2 
diabetes, these findings are often associated with NAFLD.39 
Development of such complications may be related to poor 
clinical follow-up as up to 60% of adolescents with type 2 
diabetes lack regular follow-up and have been noted to have 
Table 2 Screening recommendations for type 2 diabetes in high-
risk children and adolescents1,2,35
When: age 10 or onset of puberty, whichever occurs first
Frequency: every 2 years
Preferred screening test: fasting plasma glucose
Presence of any one of the following
  BMia .85% for age and gender
  weight for height .85%
  weight .150% of ideal weight for height
Presence of any two of the following risk factors
  Family history of type 2 diabetes in first or second degree relative
    Member/descendent of native American, African American, Hispanic 
American, Asian, or South Pacific Islander ethnic groups
    Signs of insulin resistance including acanthosis nigricans, hypertension, 
dyslipidemia, and polycystic ovarian syndrome
Abbreviation: BMi, body mass index.Journal of Multidisciplinary Healthcare 2010:3 submit your manuscript | www.dovepress.com
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higher body mass indexes and blood pressures and greater 
lipid abnormalities compared with adolescents receiving 
regular clinical care.44
Management strategies: 
medications
Effective treatment of type 2 diabetes requires a combination 
of lifestyle modification and medications. At present, data 
supporting the safe and effective treatment of type 2 diabetes 
in children and adolescents are sparse. As a result, treatments 
demonstrated to be effective in adults with type 2 diabetes 
have typically been extrapolated to adolescents. The ADA 
and International Diabetes Federation suggest initial trials 
of diet modification and exercise therapy in adolescents with 
type 2 diabetes. However, it is accepted that this is effective 
in ,10% of adolescents, and most patients will ultimately 
require pharmacological treatment.2,22
Metformin has been proven safe and effective in lowering 
fasting plasma glucose and HbA1c, and it is the recommended 
first line medication for treatment of type 2 diabetes in ado-
lescents. Metformin remains the only US Food and Drug 
Administration (FDA)-approved agent for treatment of type 2 
diabetes in the pediatric population.45 Although not approved 
by FDA for pediatric use in the United States, glimepiride 
lowers HbA1c to an equivalent degree as   metformin.   However, 
glimepiride is associated with greater weight gain and more 
frequent hypoglycemia than   metformin.46 To date, there are 
no long-term trials demonstrating safety and efficacy of 
insulin in pediatric patients with type 2 diabetes, although 
it is commonly utilized as initial therapy in symptomatic 
patients and in those presenting with diabetic ketoacidosis.2,4 
Other   medications for treatment of type 2 diabetes in adults, 
including sulfonylureas, thiazolidinediones, α-glucosidase 
  inhibitors, dipeptidyl peptidase IV inhibitors, incretin 
  mimetics, and glucagon-like peptide-1 inhibitors, are rarely 
used in the treatment of adolescents with type 2 diabetes. Fur-
ther studies evaluating the safety, efficacy, and long-term out-
comes for the treatment of type 2 diabetes in adolescents are 
needed. The Treatment Options for Type 2 Diabetes in Youth 
(TODAY) study is a multicenter study enrolling 750 children 
and   comparing metformin alone vs metformin plus rosiglita-
zone vs metformin plus intensive lifestyle intervention. This 
study is slated for completion in 2011.4,25
Although treatment with medications plays an important 
role in type 2 diabetes, the effectiveness of oral medications 
will inevitably diminish as disease progresses, and insulin will 
be required. It has been well demonstrated that   adolescents 
with type 1 diabetes have inconsistent   medication   adherence 
in spite of potentially life-threatening   consequences of 
  nonadherence to treatment. Thus, the prospects of long-
term medication adherence in adolescents with relatively 
  asymptomatic type 2 diabetes are likely to be even lower.47 
Nonpharmacologic interventions focusing on nutrition, 
activity, and lifestyle change may provide durable treatment 
options for adolescents with type 2 diabetes, provided they 
are sustained over a period of years. This may be   particularly 
  powerful in youth if modifications are adopted during the 
period in which healthy lifestyle habits are developed. At 
  present, there is little evidence or research on the best approach 
to delivering and incorporating these aspects into patient care. 
Utilization of multidisciplinary care teams to   provide com-
prehensive disease management may be useful.
Principles of multidisciplinary care
Provision of ongoing, comprehensive care for chronic 
medical illnesses such as type 2 diabetes presents unique 
challenges to our current medical system, which is generally 
designed and structured to respond to acute illness. Structural 
adaptations to provide care for chronic diseases such as type 2 
diabetes rely on periodic follow-up visits to assess the effects 
of prior interventions and develop ongoing or modified plans 
of care. In current medical systems, patients may or may 
not receive diabetes education, self-management support, 
and services to enhance self-efficacy and activation, and if 
such services are received, they are often not interrelated or 
integrated into routine medical care.
Multidisciplinary approaches to the management of type 
2 diabetes in children and adolescents build on the foundation 
of the “medical home”. Initially described by the American 
Academy of Pediatrics (AAP) in 1992,48 the patient-centered 
medical home (PCMH) serves as a model for how practices 
should respond to all patients within a practice and has 
evolved substantially in the past decade with various degrees 
of adoption and implementation throughout pediatric and 
adult practices. At present, a unifying description and defini-
tion of the PCMH is lacking, although most incorporate ele-
ments of continuity of care, patient-centered care, enhanced 
access, improved communication between patients and pro-
viders, integrated care, coordinated care, and increased use of 
information technology.49,50 Although full implementation and 
evaluation have been limited, the PCMH may be particularly 
useful in management of chronic childhood diseases, and 
evidence suggests that the medical home improves health 
outcomes in children with chronic illness.48
The chronic care model (CCM)51 provides a guide for 
multidisciplinary, team-based management of chronic Journal of Multidisciplinary Healthcare 2010:3 submit your manuscript | www.dovepress.com
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disease and may be a useful model for adolescents with 
type 2 diabetes. The CCM is built upon the idea that   effective 
chronic illness management requires comprehensive, 
  systematic change rather than simply adding new features 
to an unchanged system focused on delivery of acute care. 
Chronic care delivered in a high-quality system necessitates 
continuous relationships with a care team, individualization 
of care according to patient needs and values, anticipation 
patient needs, cooperation among clinicians, and evidence-
based care.51 The CCM also seeks to deliver patient-centered 
care, which considers an individual patient’s personal prefer-
ences, values, lifestyle, family, and cultural traditions when 
formulating health care plans. By incorporating the patient 
and family members into clinical decision making, disease 
management is shared by patients and clinicians. As a result, 
a primary goal of the multidisciplinary health care team is to 
foster independent self-care responsibility that is reflected 
in self-monitoring, problem solving, and lifestyle choices 
in the patients. Thus, rather than dictating delivery of care, 
health care providers become guides, resources, and coaches 
to empower patients in disease management.52 Adoption 
of these principles into medical practice may help achieve 
the “triple aim” of health care: improving the individual 
experience of care, improving the health of populations, and 
reducing per capita cost of care for populations.53
Medical home demonstration projects sponsored by 
the Centers for Medicare and Medicaid Services (CMS) 
in the United States, private insurers, and private funding 
are   ongoing and incorporate elements of both traditional 
PCMHs and the CCM. While the PCMH generally includes 
open access and care coordination among providers as key 
elements, the CCM does not account directly for these ele-
ments. Thus, the PCMH may be viewed as a framework for 
the implementation of the CCM.49 At this time, it is unclear 
whether the PCMH, the CCM, or an integrated approach 
achieves optimal outcomes in children with type 2 diabetes.
Additional considerations are important in adapting 
these recommendations into disease management strate-
gies for children and adolescents with type 2 diabetes. 
Provision of high-quality pediatric care must account for 
the developmental stages of childhood and their relation-
ship to diabetes understanding and diabetes management 
skills. The “4D model” describes unique considerations in 
the design, delivery, and evaluation of quality improvement 
and health services research in children. The 4 Ds include 
(1) Developmental change, (2) Dependency, (3) Differential 
epidemiology, and (4) Demographic patterns.54   Consideration 
of these factors will help facilitate the development of 
  age-appropriate, multidisciplinary health care strategies for 
children with type 2 diabetes.
Structure of the multidisciplinary 
health care team
In adult patients, multifaceted disease management programs 
have been shown to improve patient satisfaction, patient adher-
ence, and disease control across a variety of chronic medical 
conditions including diabetes.55,56 In type 2 diabetes, multidis-
ciplinary disease management programs targeting both provid-
ers and adults have been shown to significantly decrease HbA1c 
and increase patient self-care practices and self-efficacy.57,58 
Intensive management within the primary care setting utilizing 
care coordinators and clinical   pharmacists decreases HbA1c 
and cardiovascular risk factors in adults with type 2 diabetes,59 
with modest labor and program costs.60 Sustained reductions 
in HbA1c have been shown to provide significant reductions 
in health care costs and utilization.61
Although multidisciplinary management approaches to 
type 2 diabetes in adults improve glycemic control,62 evidence 
is lacking in children with type 2 diabetes. Multidisciplinary 
approaches to the management of type 2 diabetes in adoles-
cents vary according to location, experience, local expertise, 
and availability of institutional and community resources. 
Individual components of a multidisciplinary team may 
include primary care physicians, endocrinologists, dieticians, 
certified diabetes educators, pharmacists, personal trainers 
or exercise physiologists, social workers, psychologists, 
and case managers or care coordinators.63 Although current 
clinical structure may provide selected services as part of 
routine care, it is the interaction among team members and 
the cohesive, focused management philosophy that adds 
true value to multidisciplinary care.52 However, the optimal 
components, organization, and interaction between team 
members are unknown.
Adolescent and family members
In patient-centered health care, adolescents with type 2 
diabetes, parents, and family members are the center of the 
multidisciplinary health care team. The role of the patient, 
parent, and other family members in diabetes care varies 
with patient age and developmental stage. In young children, 
a family member will be the center of the health care team, 
whereas in adolescents and young adults, the patient will 
lead the team. As adolescents approach transition to adult-
oriented care, health care providers should partner with the 
family and other members of the health care team to facilitate 
progressive responsibility for self-management of diabetes Journal of Multidisciplinary Healthcare 2010:3 submit your manuscript | www.dovepress.com
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with appropriate levels of parental oversight. This fosters 
  independent   self-care responsibility that is expressed through 
self-  monitoring, utilization of blood glucose data, meal 
  planning, activity goals, and problem solving.52,64 Creating 
and   sustaining change are dependent on patient activation, and 
failure to acknowledge the need for change poses a substantial 
barrier to both patients and health care providers.52,64 Devel-
opment of multidisciplinary diabetes education strategies 
designed to enhance self-efficacy and self-management may 
increase activation among adolescents and supporting family 
members and may enhance diabetes self-care including moni-
toring of blood glucose, analyzing glucose readings, adjusting 
dietary intake, modifying physical activity, and promoting 
weight loss.52,64 As self-efficacy increases, patients accept 
greater responsibility for their diabetes and the consequences 
of   treatment choices. As this occurs, the multidisciplinary 
diabetes team focuses less on directing and dictating care and 
more on guiding and supporting individualized, collaborative 
patient management strategies.52,64
Adolescents with type 2 diabetes are unlikely to cre-
ate and sustain changes in eating habits, physical activity, 
and lifestyle without the support of family members. Ado-
lescents with type 2 diabetes come from families where 
obesity, inactive lifestyles, high-fat diets, binge eating, and 
parental diabetes are common,28 and poor control of type 2 
diabetes in parents may be detrimental to diabetes control 
in adolescents. Having family members with diabetes has 
been identified by adolescents as both positive and negative 
influences on disease management depending on the disease 
management behaviors, disease complications observed, 
and expectations modeled by others.65 Parents with poorly 
controlled diabetes may be reluctant to encourage improved 
self-management in their children with diabetes and require 
additional assistance in facilitating diabetes self-management 
in their children.66 Adolescents with type 2 diabetes and their 
parents underestimate the degree of overweight or obesity, 
and this is associated with poorer exercise, dietary intake, 
and greater barriers to change.67 Additional barriers to change 
identified by adolescents with type 2 diabetes and their par-
ents include a lack of perceived normalcy, especially with 
respect to food choices, environmental challenges at school 
and in the home, and the lack of opportunity to interact with 
other adolescents with type 2 diabetes.65,66 Adolescents with 
type 2 diabetes generally have poor diet and exercise habits, 
even if medication monitoring and adherence are adequate.68 
Effective, multidisciplinary disease management programs 
should account for family and social context, seek buy-in 
from the family unit, and engage both the patient and the 
family members responsible for care. Empowering change in 
family members has positive effects on diabetes management 
in adults.69 Collaborative participation in multidisciplinary 
disease management programs by the adolescent with dia-
betes and a parent with diabetes may create accountability 
and increase effectiveness if both adolescent and parent are 
activated and willing to change behavior. Family involve-
ment in diabetes management strategies is associated with 
fewer unhealthy behaviors,70 and this may be instrumental 
for adolescents to make successful, sustainable lifestyle 
changes, as parents commonly purchase food, prepare meals, 
and model behavior for their children.69
Primary care providers
Primary care providers play an integral role in the 
multidisciplinary diabetes care team. By establishing long-term 
relationships with adolescents with diabetes and their families, 
primary care providers facilitate health promotion, health 
maintenance, disease prevention, counseling, patient education, 
and diagnosis and treatment of acute and chronic illnesses.71 
Within the medical home and CCM, the primary care physician 
often organizes and coordinates care between members of 
the   multidisciplinary care team. Primary care providers may 
be the only members of the health care team with training in 
the delivery of comprehensive, developmentally appropriate 
health care to adolescents and young adults. Although other 
members of the multidisciplinary team may have training to 
deliver developmentally appropriate services within their scope 
of practice, the primary care physician is capable of integrating 
and coordinating care across multiple services to ensure that a 
consistent, developmentally appropriate philosophy of care is 
provided to meet the needs of each patient and family.52,64
While many adult-oriented providers have experience and 
comfort in managing type 2 diabetes, providing diabetes-
related screenings, and monitoring for disease complications, 
pediatric-oriented providers may not. Primary care provider’s 
knowledge of institutional, community, and regional diabetes 
management resources will facilitate assembly of the multidis-
ciplinary care team. Coordination of services by primary care 
providers within a medical home model facilitates comprehen-
sive diabetes care and may assist with transition and transfer 
of care from pediatric to adult health care systems.52,64
Diabetes specialists
Diabetes specialists, including endocrinologists and mid-
level providers with advanced training in diabetes, can play 
important roles in the multidisciplinary management of 
type 2 diabetes; however, availability and accessibility in Journal of Multidisciplinary Healthcare 2010:3 submit your manuscript | www.dovepress.com
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both industrialized and nonindustrialized countries may be 
limited. As the prevalence of type 2 diabetes in adolescents 
and young adults increases,12 the ability of diabetes   specialists 
to manage type 2 diabetes in this population will be even 
further limited, and alternative approaches to diabetes care 
will be needed. Although specialist care may result in better 
diabetes-specific process measures, it has not been consis-
tently demonstrated to improve survival in adults with type 
2 diabetes.72,73 Children with type 2 diabetes may be more 
likely to receive care from diabetes specialists as a result of 
pediatric primary care providers limited comfort and expe-
rience caring for type 2 diabetes. However, it is currently 
unknown if care by diabetes specialists improves long-term 
outcomes in children with type 2 diabetes.
While diabetes specialists should be part of the multi-
disciplinary care team, they may not need to be involved 
in the management of routine type 2 diabetes if appropri-
ate services and infrastructure are in place. Long-distance 
consultation via telephone, computer, or video conferencing 
with diabetes specialists may be sufficient when expert con-
sultation is needed. Diabetes specialists may also enhance 
diabetes management within the team by designing and 
leading structured continuing medical education programs 
on medical management of type 2 diabetes, disease manage-
ment guidelines, and prevention of secondary complications. 
Despite clinical practice guidelines set forth by the ADA 
and other expert panels, there remains wide variation in the 
management of type 2 diabetes among pediatric diabetes 
specialists. In a recent study, pediatric endocrinologists often 
failed to follow recommendations for screening and manage-
ment of hypertension, hyperlipidemia, microalbuminuria, and 
foot care, and only 34% of providers were concordant with 
all guidelines.74 Although many reasons could explain this 
variation, there is significant room for improvement. Greater 
attention to type 2 diabetes guidelines in youth, enhanced 
provider education programs, and increased collaboration 
among primary care providers and diabetes specialists may 
enhance comprehensive diabetes management within the 
medical home and help accommodate the increasing burden 
of diabetes care on the health care system.
Diabetes educators and nutritionists
In order to create and sustain changes in lifestyle, diet, 
physical activity, and diabetes management, diabetes-related 
education and nutritional curricula are needed to establish a 
foundation of patient and provider knowledge upon which 
more comprehensive disease management strategies can 
build. Diabetes education is necessary but not sufficient 
to enhance self-management in patients with diabetes.75 
  Creation of diabetes education programs that are sensitive 
to each individual patient’s level of literacy and numeracy 
may enhance the effectiveness of diabetes and nutrition 
  education. Literacy- and numeracy-sensitive diabetes educa-
tion programs76 have been shown to improve self-efficacy 
and diabetes control.77 The use of such tailored education 
programs may also improve safety and quality of care.78
Family-centered, group diabetes education programs, 
such as the Families, Adolescents, and Children’s   Teamwork 
Study (FACTS),79,80 have demonstrated significant improve-
ment in glycemic control among adolescents type 1   diabetes. 
This clinic-integrated education program delivered by 
members of a multidisciplinary care team, including nurse 
specialists,   physicians, and dieticians, addresses teamwork, 
communication, interdependence or shared responsibility for 
diabetes care, and letting go in addition to standard nutrition, 
physical activity, and glucose monitoring aspects of diabetes 
management. Such programs may provide a framework for 
the development of similar programs for adolescents with 
type 2 diabetes.
Diabetes education programs targeting adolescents with 
type 2 diabetes and their parents face unique challenges due 
to high rate of risk factors, lifestyle choices, and comorbid 
type 2 diabetes among family members.28 Families contain-
ing multiple members with type 2 diabetes demonstrate poor 
glycemic control among both parents and children, suggest-
ing that interventions targeted at the adolescent alone may 
be insufficient.28 A standardized diabetes education program 
was developed for adolescents with type 2 diabetes and 
implemented at the time of enrollment for all participants 
in the TODAY study.75 Adolescents and a family member 
attend the sessions together. The curriculum is led by a 
certified diabetes educator and focuses on understanding 
disease physiology, disease management, and progressive 
skill building. Mastery of skills is measured by quizzes and 
required for progression through the program. Further studies 
on the effectiveness and implementation of such programs 
in adolescents with type 2 diabetes are needed.
Behavioral counselors  
and activity coaches
The availability of psychologists, counselors, therapists, 
and psychiatrists for consultation with the multidisciplinary 
diabetes management team is an important consideration for 
many patients. Adolescents with type 2 diabetes are often 
faced with the diagnosis of a chronic disease during a time 
of increasing autonomy.52,64 Stress, anxiety, depressed mood, Journal of Multidisciplinary Healthcare 2010:3 submit your manuscript | www.dovepress.com
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and other emotional stressors may contribute to poor disease 
control in adolescents and young adults, and addressing 
these barriers may facilitate behavioral change and improve 
clinical outcomes.68
The TODAY study is currently utilizing Personal Activity 
and Nutrition Leaders (PALs) as a portion of the intensive 
lifestyle intervention program. Through regular contact with 
the adolescent and participating family support person, PALs 
encourage healthy eating, physical activity, and restructuring 
of the home environment. In addition to examining the effect 
of medication vs medication plus lifestyle modification, the 
study is collecting data on physical activity and accelerometer 
data to measure physical activity and fitness.81
The role of activity coaches and personal trainers within 
multidisciplinary diabetes care teams has not been well stud-
ied. Intensive lifestyle modification with diet and exercise 
is superior to treatment with metformin alone in preventing 
type 2 diabetes in adults with impaired glucose tolerance.82 
Regular physical activity has been shown to reduce abdominal 
visceral fat, increase insulin sensitivity, decrease insulin resis-
tance, improve lipid profiles, reduce inflammation, improve 
endothelial function, and reduce blood pressure in patients 
with type 2 diabetes.83 The 2008 US Department of Health and 
Human Services Physical Activity Guidelines recommended 
that children and adolescents should get at least 60 minutes 
of physical activity daily, with the majority of this time 
composed of moderate–vigorous intensity aerobic physical 
activity distributed over at least 3 days per week.83 However, 
in children, greater focus on reduction of sedentary activity 
and less focus on structured exercise programs appear to be 
more effective than organized high-intensity exercise.63
Care coordinators, case managers,  
and social workers
Utilization of case management and team management strate-
gies in adults with type 2 diabetes results in superior glyce-
mic control compared with isolated interventions targeting 
patient education and provider education or creating patient 
registries.62 Care coordinators enhance disease management 
by facilitating communication and coordination among pro-
viders, subspecialists, and other team members. Coordinated 
delivery of services among members of the health care team 
allows linkage of targeted patient and family diabetes educa-
tion, demonstration of practical dietary and activity changes 
by nutrition and exercise specialists, reinforcement of clinical 
importance of disease control by providers, and follow-up 
by the care coordinator to address family-specific issues that 
may facilitate or pose barriers to change.
Linkage of the multidisciplinary team allows delivery 
of a unified philosophical diabetes management approach 
and provision of ongoing, real-time follow-up by care coor-
dinators. Contact with the multidisciplinary team between 
scheduled clinical visits allows follow-up of home glucose 
monitoring data, dietary changes, activity goals, and medi-
cation titration to occur between scheduled clinic visits. 
Frequent interactions by telephone and computer-based 
technologies may increase patient accountability and adher-
ence and may facilitate more rapid changes in the diabetes 
treatment plan to improve disease   control. A recent study in 
adolescents with type 1   diabetes   demonstrated improvement 
in self-management,   problem   solving, and glucose control 
through the use of an Internet portal.84 Utilization of such 
technology-based interfaces may be particularly useful in 
disease management of adolescents.
The role of care coordinator may be filled by nurses, case 
managers, pharmacists, social workers, or other individuals. 
  Multidisciplinary diabetes management programs in adults 
utilizing care coordinators who are allowed to make medication 
changes independent of clinicians have greater reductions in 
HbA1c levels (0.96% vs 0.41%) compared with care coordina-
tors who were not independent.62 Utilizing clinical pharmacists 
as case managers or care coordinators within adult multidisci-
plinary diabetes teams creates significant reductions in HbA1c 
(2.1% vs 0.9%).85 Thus, encouraging care coordinator indepen-
dence with appropriate support from the multidisciplinary care 
team may be a useful strategy to enhance diabetes management 
and glucose control in adolescents with type 2 diabetes; however, 
studies demonstrating such findings in youth are lacking.
Utilization of community health workers as members of 
the multidisciplinary diabetes team has been shown to reduce 
emergency room visits and improve diabetes control in 
minority populations and underserved areas, suggesting that 
community-based, culturally tailored programs may enhance 
diabetes outcomes.86–88 Social workers are also important 
members of the multidisciplinary diabetes team and provide 
links to institutional, state, and community resources. Social 
workers can help identify local community centers, parks, and 
other recreational activities within the community to increase 
the physical activity of adolescents and families with type 2 
diabetes. They may also be able to assist families with access 
issues and navigating insurance resources so that continuous 
insurance coverage can be arranged as adolescents age out 
of their parent’s insurance policies. When adolescents do not 
have insurance, social workers can assist with enrollment in 
federally funded programs or help find indigent care clinics 
within the community.Journal of Multidisciplinary Healthcare 2010:3 submit your manuscript | www.dovepress.com
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Implementation of multidisciplinary 
management in type 2 diabetes
Although the incidence and prevalence of type 2 diabetes 
in youth are increasing,2,3,20 the population density of 
adolescents with type 2 diabetes remains relatively low. This 
creates intrinsic difficulty in identifying patients, centralizing 
care within geographic areas, and establishing and sustaining 
clinic-based multidisciplinary diabetes care teams. Clinical 
follow-up among adolescents with type 2 diabetes is anecdot-
ally low.89 Although the reasons for this are poorly understood, 
it may be related in part to the lack of acute events when the 
disease is poorly controlled and the relatively silent disease 
onset and progression early in the course of type 2 diabetes. 
Additionally, the implementation of multidisciplinary care 
teams, CCM principles, and PCMH infrastructure face pay-
ment and reimbursement challenges in start-up costs, daily 
operations, and long-term sustainability. At present, it is 
unclear if cost savings from such models will adequately 
cover operational costs to allow sustainability.49,90 Although 
these challenges may limit the development of clinic-based 
multidisciplinary care teams for adolescents with diabetes, 
multidisciplinary management principles are applicable and 
may increase the quality of care delivered. Utilization of 
technology-based communication, education strategies, and 
disease management tools via telephone, computer, Internet,84 
or texting may provide novel approaches to diabetes manage-
ment without dependence on traditional face-to-face clinical 
encounters.
In spite of evidence supporting the use of multidis-
ciplinary management strategies in adults with type 2 
diabetes,62 published program descriptions, implementation 
studies, and program evaluations are lacking in adolescents 
with type 2 diabetes. Furthermore, information on the safety, 
efficacy, and long-term consequences of type 2 diabetes treat-
ment and disease progression in youth is lacking. To date, the 
TODAY study is the largest study of type 2 diabetes in youth, 
and it should provide critical information on the natural his-
tory of disease in youth and the comparative effectiveness 
of medication and lifestyle interventions in youth with type 
2 diabetes.81 This study, although rigorously controlled and 
defined, contains many aspects of a multidisciplinary care 
team, including participation by adolescents and a family sup-
port person in diabetes management; utilization of diabetes 
educators with curricula geared towards both adolescents 
and caregivers; intensive lifestyle intervention with personal 
activity, behavioral, and nutrition coaches; and management 
of comorbid conditions, such as dyslipidemia, hypertension, 
and microalbuminuria.81 Lessons learned from this study 
could significantly inform the development of disease man-
agement programs in adolescents with type 2 diabetes.
Future work
If experience with multidisciplinary management of type 2 
diabetes in adults holds true, creation of multidisciplinary 
care teams for type 2 diabetes in adolescents may improve 
disease control and delay the development of diabetes-related 
complications. Given the relatively low, although increasing, 
prevalence of type 2 diabetes in youth, multidisciplinary 
services will likely need to coordinate and organize care 
over broad geographic areas. Although the creation of 
in-clinic and on-site multidisciplinary teams may not be 
practical or economical in all areas, development of hybrid, 
multidisciplinary diabetes management strategies combining 
on-site clinical encounters with off-site remote disease 
management may facilitate more comprehensive, organized, 
convenient, and economical care.90 Utilization of electronic 
medical records and development of technology interfaces 
utilizing cellular phones, computers, Internet resources, and 
social networking may facilitate engagement of adolescents 
in disease management and improve diabetes control. Devel-
opment, implementation, and evaluation of multidisciplinary 
care models in youth with type 2 diabetes are urgently needed, 
and experiences from disease management programs for 
adults with type 2 diabetes should facilitate development.
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